Navigation Links
New Studies Demonstrate Clinical Utility and Validity of CancerType ID® Molecular Classifier
Date:3/22/2012

the oncology community. The company operates a CLIA-certified, CAP-accredited diagnostic service laboratory in San Diego, CA to perform its proprietary molecular diagnostic tests: breastcancerindex, which is a prognostic test that provides quantitative risk assessment of distant recurrence in patients diagnosed with estrogen receptor positive and lymph node negative breast cancer; and CancerTYPE ID, which uses the differential expression of 92 genes to aid in the determination of tumor site of origin. For more information, call 1-858-587-5870 or visit www.bioTheranostics.com.

About bioMerieux

Advancing Diagnostics to Improve Public Health

A world leader in the field of in vitro diagnostics for more than 45 years, bioMerieux is present in more than 150 countries through 39 subsidiaries and a large network of distributors. In 2011, revenues reached euro 1.427 billion with 87% of sales outside of France.

bioMerieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

bioMerieux is listed on the NYSE Euronext Paris market (Symbol: BIM – ISIN: FR0010096479).

Other information can be found at www.biomerieux.com

FOR INFORMATION:

bioTheranostics
Tim Schofield
Tel: + 1 858 587 5890
tim.schofield@biotheranostics.com

bioMerieux
Koren Wolman-Tardy
Tel: + 011 33 6 13 94 51 14
m
'/>"/>

SOURCE bioTheranostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
4. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
5. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
8. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
9. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
10. Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
11. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015  The growing threat posed ... a sense of urgency to the development of ... R&D costs and provide incentives for new drug ... Logo - http://photos.prnewswire.com/prnh/20150331/195565LOGO ... Product and Pipeline Analysis of the Antibacterial Drugs ...
(Date:3/30/2015)... 31, 2015 The Allen Institute for ... to define and advance the state-of-the-art digital reconstruction ... today, called BigNeuron, aims to create reliable high-throughput ... branches that make up individual neurons: a crucial ... information. "In our quest to ...
(Date:3/30/2015)... and BRISBANE, Calif., March 30, 2015 Shareholder ... the proposed acquisition of Hyperion Therapeutics, Inc. (NASDAQ: ... HZNP ).  On March 30, 2015, the two companies ... to which Horizon will acquire Hyperion.  Under the terms ... cash for each share of Hyperion common stock. ...
Breaking Medicine Technology:Development and Commercialization of Antibacterial Drugs to Speed Up 2Development and Commercialization of Antibacterial Drugs to Speed Up 3International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 2International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 3International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 4International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 5International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 6Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 2Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 3
... WESTMINSTER, Colo., Dec. 27 Allos,Therapeutics, Inc. (Nasdaq: ... Data,Monitoring Committee (DMC) has completed the pre-specified 65-patient,safety ... 2 PROPEL trial of,PDX (pralatrexate) in patients with ... recommended that the trial continue per the,protocol. This ...
... Traditional Approval -, YARDLEY, Pa., Dec. 21 ... Supplemental New Drug Application (sNDA) to the U.S. ... (PI) PREZISTA(TM),(darunavir) tablets, which seeks traditional approval and ... adults. The application includes 48-week data from two,Phase ...
Cached Medicine Technology:Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 2Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 3Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 4Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 5Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 2Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 3Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 4Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 5
(Date:3/31/2015)... 31, 2015 Medical Technology Solutions of ... Practice Edition 2, allowing them to offer the most ... 24 physicians or less. Dragon Medical Practice Edition 2 ... quality patient records. , "MTSOA is constantly looking ... our clients. Our goal has always been to look ...
(Date:3/31/2015)... March 31, 2015 St. Joseph Medical ... network of leading healthcare systems, major physician groups and ... for the benefit of patients. The health information exchange ... supports well coordinated care throughout the continuum of services ... long tradition of providing services to a broad cross ...
(Date:3/31/2015)... NV (PRWEB) March 31, 2015 An ... the most important ligaments in the leg providing stability, ... presenting their study at today’s Specialty Day meeting of ... ) utilized MRI data to determine the potential for ... is currently understood about the healing of meniscus tears ...
(Date:3/31/2015)... For bariatric health professionals who want better ... their investment, Rice Lake Weighing Systems introduces ... April 8-12 at the Colorado Convention Center in Denver, ... offices, Rice Lake’s BCA uses the most advanced bio-electrical ... 2015 delivers clinical and practical knowledge about a variety ...
(Date:3/31/2015)... AB (PRWEB) March 31, 2015 ... to patients of Calgary and surrounding areas. External ... patients with coronary artery disease, specifically stable coronary ... EECP or ECP, is used extensively all over ... disease and now Calgarians (Albertans) are extremely fortunate ...
Breaking Medicine News(10 mins):Health News:Medical Technology Solutions of America Announces Availability of Dragon® Medical Practice Edition 2 for Medical Professionals 2Health News:St. Joseph Medical Center Joins Other Leading Healthcare Systems Participating in Greater Houston Healthconnect 2Health News:New Way to Evaluate Meniscus Tear Outcomes 2Health News:Rice Lake Weighing Systems’ Body Composition Analyzer On Display at Obesity Medicine 2015 2Health News:New Heart Disease Treatment Called External Counterpulsation (EECP) helps people of Alberta Who Have Failed or Are Not Suitable For Heart Stents or Surgery 2
... chronic autoimmune disease that strikes children between the ages ... JRA have joint pain, stiffness, and swelling and some ... growth, damage joints, and lead to disability in adulthood. ... the same drugs prescribed to adults with inflammatory diseases: ...
... use of blood-boosting drugs in anemia patients , , THURSDAY, May ... linked to severe diabetic eye and kidney diseases, a new ... at the John A. Moran Eye Center at the University ... and end-stage renal disease (ESRD) and 954 diabetic patients without ...
... Want to Join CNA/NNOC, Reject Service Employees ... ... three St. Rose,Dominican hospitals in Henderson and Las Vegas early Thursday cast ... behind their current representative, the Service,Employees International Union Local 1107., In ...
... 14th,the Aspen Institute Health Stewardship Project will release ... Obama, and Hillary,Rodham Clinton, to a questionnaire on ... provide analysis of the candidates, responses,and discuss the ... Zogby,International., The co-chairs will comment on where ...
... on estrogen receptors prolongs the life of these growth-driving ... scientists at Emory University,s Winship Cancer Institute. , ... issue of the journal Molecular Cell. , Most breast ... in the presence of the hormone estrogen. Their presence ...
... New Women,s Advanced Blood Pressure Monitor Elite 7300W is Designed ... Clinically Validated Specifically for Women, ... cause of death for women over the age of 25, ... Today, Omron,Healthcare, Inc. introduces the Elite 7300W home blood pressure ...
Cached Medicine News:Health News:Study affirms effectiveness of medication for juvenile rheumatoid arthritis 2Health News:Study affirms effectiveness of medication for juvenile rheumatoid arthritis 3Health News:Gene Variant Boosts Risk of Severe Diabetic Eye, Kidney Diseases 2Health News:Dramatic Las Vegas Vote by RNs for Change 2Health News:Dramatic Las Vegas Vote by RNs for Change 3Health News:Previously unseen switch regulates breast cancer response to estrogen 2Health News:Omron Makes Blood Pressure Monitoring Easy for Women at Any Stage of Life, Including Pregnancy 2Health News:Omron Makes Blood Pressure Monitoring Easy for Women at Any Stage of Life, Including Pregnancy 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: